As of 2026-04-05, the Relative Valuation of Entheon Biomedical Corp (ENBI.CN) is 0.10 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.10 CAD, the upside of Entheon Biomedical Corp based on Relative Valuation is 0.6%.
The range of the Relative Valuation is 0.10 - 0.10 CAD.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | -4.3x - -4.3x | -4.3x |
| Fair Price | 0.10 - 0.10 | 0.10 |
| Upside | 0.6% - 0.6% | 0.6% |
| Date | P/E |